-
1
Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells
Published 2025-01-01Subjects: Get full text
Article -
2
Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors
Published 2025-12-01Subjects: Get full text
Article